Izzat T Raheem

8PUBLICATIONS
29CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsMedical bacteriologyBiologically active moleculesInnate immunityBacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 26, 2025
MK-8527 is a novel inhibitor of HIV-1 reverse transcriptase translocation with potential for extended-duration dosing.

Izzat T Raheem, Vinay Girijavallabhan, Kerry L Fillgrove

|Aug 22, 2024
Cerastecin Inhibition of the Lipooligosaccharide Transporter MsbA to Combat Acinetobacter baumannii: From Screening Impurity to In Vivo Efficacy.

Jason W Skudlarek, Andrew J Cooke, Helen J Mitchell

|Aug 14, 2024
Discovery of Broad-Spectrum Herpes Antiviral Oxazolidinone Amide Derivatives and Their Structure-Activity Relationships.

Michael A Plotkin, Marc Labroli, Jeffrey Schubert

|May 20, 2024
Stabilized trimeric peptide immunogens of the complete HIV-1 gp41 N-heptad repeat and their use as HIV-1 vaccine candidates.

Chengwei Wu, Izzat T Raheem, Debbie D Nahas

|Apr 22, 2024
Cerastecins inhibit membrane lipooligosaccharide transport in drug-resistant Acinetobacter baumannii.

Hao Wang, Andrii Ishchenko, Jason Skudlarek

|Jan 10, 2023
Discovery of MK-8189, a Highly Potent and Selective PDE10A Inhibitor for the Treatment of Schizophrenia.

Mark E Layton, Jeffrey C Kern, Timothy J Hartingh

Pageof 2

Frequent Collaborators

2 joint publications

Douglas C Beshore

2 joint publications

Scott S Walker

2 joint publications

Jason W Skudlarek

1 joint publications

Andrew M Haidle